Tg Therapeutics (TGTX) Tax Provisions (2023 - 2025)
Historic Tax Provisions for Tg Therapeutics (TGTX) over the last 3 years, with Q3 2025 value amounting to -$365.0 million.
- Tg Therapeutics' Tax Provisions fell 9135000.0% to -$365.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$359.7 million, marking a year-over-year decrease of 7336843.18%. This contributed to the annual value of $2.2 million for FY2024, which is 46692.31% up from last year.
- Tg Therapeutics' Tax Provisions amounted to -$365.0 million in Q3 2025, which was down 9135000.0% from $2.7 million recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' Tax Provisions registered a high of $2.7 million during Q2 2025, and its lowest value of -$365.0 million during Q3 2025.
- In the last 3 years, Tg Therapeutics' Tax Provisions had a median value of $395000.0 in 2023 and averaged -$44.9 million.
- Data for Tg Therapeutics' Tax Provisions shows a peak YoY increase of 130689.66% (in 2025) and a maximum YoY decrease of 9135000.0% (in 2025) over the last 5 years.
- Quarter analysis of 3 years shows Tg Therapeutics' Tax Provisions stood at $390000.0 in 2023, then surged by 441.28% to $2.1 million in 2024, then tumbled by 17390.38% to -$365.0 million in 2025.
- Its last three reported values are -$365.0 million in Q3 2025, $2.7 million for Q2 2025, and $408000.0 during Q1 2025.